Healthsens develops enzymatic and immunological biosensors, creating POCT (Point of Care Testing) devices for the diagnosis and monitoring of the major impact diseases affecting the worldwide population.
POCT device for early diagnosis and monitoring of kidney disease.
Enzymatic creatinine biosensor that measures the creatinine concentration and estimates the glomerular filtration rate in a single drop of peripheral blood, fundamental parameters for the early diagnosis and monitoring of kidney disease.
POCT device for the early detection of prostate cancer (prostate health index PHI).
Bio-immunosensor that will analyze the biomarkers associated with prostate cancer with a single drop of patient’s serum. For the construction of these HEALTHSENS sensors a completely new methodology is being developed based on the use of magnetic nanoparticles.